Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 21.04 Min. order: 1 piece ★★★★★ 4.9 (173 reviews) Sold : Login>>
Game changing' data: New obesity drugs tied to major weight loss, may reduce CV risk US$ 21.98 Min. order: 1 piece ★★★★★ 4.9 (30 reviews) Sold : Login>>
Retatrutide - Possibly better than semaglutide b/c lower nausea/side effect profile, but higher heart rate US$ 28.67 Min. order: 1 piece ★★★★★ 4.8 (174 reviews) Sold : Login>>
Cagrilintide Peptide for Weight Loss US$ 24.66 Min. order: 1 piece ★★★★★ 4.7 (298 reviews) Sold : Login>>